SIMPLEX TRADING, LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$0
-100.0%
200
-98.3%
0.00%
Q2 2019$72,000
+176.9%
11,707
+108.4%
0.00%
Q1 2019$26,000
-7.1%
5,618
+25.6%
0.00%
Q3 2018$28,000
+75.0%
4,473
+116.9%
0.00%
Q2 2018$16,000
-90.1%
2,062
-90.5%
0.00%
-100.0%
Q1 2018$162,000
+74.2%
21,754
+38.5%
0.01%
+75.0%
Q4 2017$93,000
-48.9%
15,710
-36.7%
0.00%
-42.9%
Q3 2017$182,000
+1113.3%
24,812
+994.0%
0.01%
+600.0%
Q2 2017$15,000
+275.0%
2,268
+338.7%
0.00%
Q4 2016$4,000
-83.3%
517
-86.9%
0.00%
-100.0%
Q3 2016$24,000
-7.7%
3,942
-34.5%
0.00%0.0%
Q1 2016$26,000
+23.8%
6,018
+71.5%
0.00%0.0%
Q4 2015$21,0003,509
+5382.8%
0.00%
Q3 2015$0
-100.0%
64
-96.8%
0.00%
-100.0%
Q2 2015$14,000
-30.0%
2,010
-41.8%
0.00%
-50.0%
Q1 2015$20,0003,4550.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,583,925$8,007,0001.48%
Phocas Financial Corp. 1,022,708$5,169,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,776,490$8,980,0000.32%
FARALLON CAPITAL MANAGEMENT LLC 7,350,000$37,154,0000.28%
NEXPOINT ASSET MANAGEMENT, L.P. 716,880$3,624,0000.23%
J. Goldman & Co LP 499,698$2,526,0000.19%
PINNACLE ASSOCIATES LTD 1,257,098$6,355,0000.15%
CARILLON TOWER ADVISERS, INC. 3,948,024$19,957,0000.14%
EAGLE ASSET MANAGEMENT INC 4,504,094$22,768,0000.12%
Worth Venture Partners, LLC 32,956$167,0000.10%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders